Actelion and J&J close to sealing deal?

Johnson & Johnson and Actelion are reported to be asking Switzerland's takeover board about the viability of a complicated takeover deal the U.S. healthcare company is discussing with the Swiss biotech firm. Ciara Lee reports.

Read more